Tandem Sure Has Been Busy Lately. What’s Up with That?

In the last few months, Tandem Diabetes Management has made an acquisition and signed deals with two of medtech's biggest powerhouses - Abbott Laboratories and Medtronic. But what does it all mean? MD+DI's Managing Editor Omar Ford tries to make sense of the companies recent momentum.